Copyright ©ERS Journals Ltd 2008 Air travel and hypoxaemia in real lifeDept of Pulmonology, Faculty of Medicine, University of Porto, Hospital de São João, Porto, Portugal. To the Editors: We read with great interest the paper by Coker et al. 1 in an issue of the European Respiratory Journal. The authors conducted the largest prospective study into the outcomes of flights in patients with various respiratory diseases, showing that 18% suffered respiratory symptoms. They concluded that, although air travel seems generally safe in this population of patients under specialist respiratory care, more detailed studies with oximetry monitoring during flight should be performed to determine which patients are most at risk. The evaluation of the risk of in-flight hypoxaemia has been determined by studies performed in altitude chambers or by hypoxic gas mixture challenge 2. However, extrapolating the findings to real flights may be misleading, due to the higher altitudes attained by newer aircraft, longer duration of altitude exposure and passengers activity inside the aircraft 3.
We have evaluated transcutaneous arterial oxygen saturation (Sa,O2) using Pulsox 3iA (Minolta, Tokyo, Japan), a finger pulse oximeter with a 24-h internal memory and dedicated software (Pulsox DS-3; Minolta) for viewing and analysis of the recordings. Data was acquired from 10 healthy adults (medical staff from the Dept of Pulmonology, Faculty of Medicine, University of Porto, Hospital de São João, Porto, Portugal) with a mean±SD age of 38.9±13.1 yrs, of whom four were female and six were male. Measurements were started just before take-off and ended after landing, for 20 commercial long-distance flights (LFs; The investigation was carried out in different aircraft models of European and American airline companies in round-trip flights: 10 flights in Airbus A320; nine flights in Airbus A310; one flight in Airbus A319; eight flights in Fokker 100; three flights in Boeing 737; two flights in Boeing 757; one flight in Boeing 777; two flights in McDonnell Douglas; and two flights in BA200. Examples of LFs were Lisbon–New York, Los Angeles–Paris, New York–San Francisco and Porto–Berlin; SFs were Lisbon–Rome, Porto–Paris, Porto–Lisbon and New York–Toronto.
The mean±SD (range) monitoring duration for LFs was 5.1±2.2 (2.2–9.2) h and for SFs was 1.0±0.6 (0.5–2.0) h. On average, the maximal desaturation (difference between baseline and minimum Sa,O2) achieved was 12.8±6.3% for LFs and 4.2±2.6% for SFs (p = 0.001). While in all LFs, subjects reached a minimum Sa,O2
We also observed that Sa,O2 dropped during meals, walking along the aisle and especially in the lavatories (fig. 1 Oxygen desaturation values observed in our study seem variable between subjects, flights and planes. The greater desaturation during LFs in healthy subjects is consistent with the data of Coker et al. 1, who reported worsening symptoms mainly in patients in whom average flight duration was 7.6 h. As intermittent hypoxia is an effective stimulus for evoking cardiorespiratory responses, repetitive 4% desaturations (an original finding) may also contribute to the detrimental effects of air travel 4. In conclusion, we believe that oxygen saturation levels obtained in real life may be very useful for monitoring the health impact of flying and an important measurement to better determine patients at risk. Statement of interest None declared.
REFERENCES
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||